10 results match your criteria: "India. Electronic address: sunil.gairola@seruminstitute.com.[Affiliation]"

Article Synopsis
  • * A new method was developed to analyze the MSD of MenFive, which faced challenges due to the complexity of the vaccine's composition and various testing conditions, including different columns and temperatures.
  • * Results showed a wide range of molecular sizes (200 to 19,000 kDa), with the most common size between 1,000 and 8,000 kDa, indicating that understanding MSD helps in assessing the effectiveness and consistency of the vaccine.
View Article and Find Full Text PDF
Article Synopsis
  • - A new DOC-HCl method was developed for estimating free polysaccharide content in Meningococcal serogroups A, C, Y, W, and X within pentavalent vaccines, offering a practical alternative to the ultra-filtration technique.
  • - Two specific DOC-HCl formulations were created for different serogroups with varying hydrochloric acid concentrations, ensuring effective protein-DOC complex precipitation and enhanced accuracy in polysaccharide measurement.
  • - The method demonstrated robust performance with good recovery rates (70-130%), low variability (2-14%), and no interference from assay components, making it suitable for quality control in multivalent vaccines.
View Article and Find Full Text PDF

We report here the development and validation of CE-SDS method for purity analysis of Acellular Pertussis vaccine components viz. purified Pertussis toxin (PTx), purified Filamentous haemagglutinin (FHA), and Pertactinantigen (PRN). The method was found to be specific and showed excellent linearity at a concentration range of 15.

View Article and Find Full Text PDF

Meningococcal A Conjugate Vaccine (MenAfriVac) is the world's first Monovalent Conjugate Vaccine against Neisseria Meningitidis serogroup A which has obtained Controlled Temperature Chain (CTC) label claim of "stable upto 40°C for 4 days prior to reconstitution" developed by Serum Institute of India Pvt. Ltd. Pune, India and the vaccine was granted permission from World health Organization.

View Article and Find Full Text PDF

Multidose presentation of vaccines is the most preferred choice, for mass immunization particularly during pandemics. WHO also recommends multidose containers of fill finished vaccines for programmatic suitability and global immunizations programmes. However, multidose vaccine presentations requires inclusion of preservatives to prevent contaminations.

View Article and Find Full Text PDF

Methylated derivatives of cyclodextrins such as DIMEB (2,6-di-O-methyl)-β-cyclodextrin or Heptakis is commonly used as culture medium modifier in manufacturing of pertussis antigens for promoting the growth of bacteria. We report here development and validation of a spectrophotometric method for estimation of DIMEB in different product matrices of pertussis vaccine antigens i.e.

View Article and Find Full Text PDF

Neurovirulence, viscerotropism and immunogenicity of live attenuated yellow fever 17D vaccine virus in non-human primates.

Vaccine

January 2023

Department of Infectious Disease Research, CRO Services, Southern Research Institute, 2000 Ninth Avenue South, Birmingham, AL 35205, USA. Electronic address:

Yellow fever vaccine associated neurovirulence and viscerotropism have been reported by various countries. In this study, the neurovirulence, viscerotropism and immunogenicity of yellow fever vaccine seed lots (master and working) and final product manufactured at Serum Institute of India (SII) were evaluated in cynomolgus monkeys. WHO reference virus 168-73 and Stamaril™ as a control vaccine was used for comparison.

View Article and Find Full Text PDF

Rapid, high throughput protein estimation method for saponin and alhydrogel adjuvanted R21 VLP Malaria vaccine based on intrinsic fluorescence.

Vaccine

January 2022

Quality Control Department, Serum Institute of India Pvt. Ltd, 212/2, Soli Poonawalla Rd, JJC Colony, Suryalok Nagari, Hadapsar, Pune, Maharashtra 411028, India. Electronic address:

Protein content estimation of recombinant vaccines at drug product (DP) stage is a crucial lot release and stability indicating assay in biopharmaceutical industries. Regulatory bodies such as US-FDA and WHO necessitates the quantitation of protein content to assess process parameters as well as formulation losses. Estimation of protein content at DP stage in presence of adjuvants (e.

View Article and Find Full Text PDF

Meningococcal vaccines have been developed over the years, to control outbreaks of meningitis. There are 12 immunologically distinct serogroups of which, A, B, C, W, Y and X are predominant and invasive in nature. Meningococcal vaccines can be sorted out as, polysaccharide vaccines, polysaccharide protein conjugate vaccines or protein based (independent of polysaccharides) vaccines.

View Article and Find Full Text PDF

The analysis of residual sodium deoxycholate (DOC); a detergent of biological origin used in manufacturing of polysaccharide vaccines is challenging due to complex sample matrices and the lack of suitable methods. Here we report, rapid and sensitive high-performance liquid chromatography-refractive index (HPLC-RI) and tandem mass spectrometry (HPLC-MS/MS) methods for estimation of residual DOC in pneumococcal polysaccharides. For HPLC-RI method, separation was achieved using Luna C18 column and mobile phase compositions of acetonitrile: methanol: 20 mM sodium acetate (60:05:35% v/v).

View Article and Find Full Text PDF